Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer’s disease

There is growing evidence that nicotine is associated with positive outcomes related to Alzheimer’s Disease and Parkinson’s Disease.


The currently available therapies for Alzheimer’s disease (AD) and related forms of dementia are limited by modest efficacy, adverse side effects, and the fact that they do not prevent the relentless progression of the illness. The purpose of the studies described here was to investigate the neuroprotective effects of the nicotine metabolite cotinine as well as a small series of cotinine and nicotine analogs (including stereoisomers) and to compare their effects to the four clinically prescribed AD therapies.

Keywords: Neuroprotection, nicotinic, multi-target-directed ligands, multifunctional compounds, amyloid, glutamate, excitotoxicity, neurodegeneration, dementia, disease modifying

Read More